Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Coates

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Cancer Research|January 1, 1984
Influence of cellular DNA content on survival in advanced ovarian cancerM L Friedlander, D W Hedley, I W Taylor, et al.
British Journal of Cancer|April 15, 2010
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancerC K Lee, M R Stockler, A S Coates, et al.
Cancer Treatment Reports|May 1, 1982
Phase II study of AMSA in patients with advanced ovarian cancerJ H Kearsley, A S Coates, R M Fox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA S Coates, A Childs, K Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group studyC I Falkson, J Ibrahim, J M Kirkwood, et al.
Cancer Treatment Reports|January 1, 1985
Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinomaJ P Page, J A Levi, R L Woods, et al.
Cancer|September 18, 1998
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patientsM J Quinn, K A Crotty, J F Thompson, et al.
Cancer Treatment Reports|January 1, 1982
Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administrationR R Reddel, R F Kefford, J M Grant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study GroupA S Coates, C Hürny, H F Peterson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinomaA M Liberati, J G Voelkel, E C Borden, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Cancer Research|January 1, 1984
Influence of cellular DNA content on survival in advanced ovarian cancerM L Friedlander, D W Hedley, I W Taylor, et al.
British Journal of Cancer|April 15, 2010
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancerC K Lee, M R Stockler, A S Coates, et al.
Cancer Treatment Reports|May 1, 1982
Phase II study of AMSA in patients with advanced ovarian cancerJ H Kearsley, A S Coates, R M Fox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1992
Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetronA S Coates, A Childs, K Cox, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group studyC I Falkson, J Ibrahim, J M Kirkwood, et al.
Cancer Treatment Reports|January 1, 1985
Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinomaJ P Page, J A Levi, R L Woods, et al.
Cancer|September 18, 1998
Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patientsM J Quinn, K A Crotty, J F Thompson, et al.
Cancer Treatment Reports|January 1, 1982
Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administrationR R Reddel, R F Kefford, J M Grant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2000
Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study GroupA S Coates, C Hürny, H F Peterson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinomaA M Liberati, J G Voelkel, E C Borden, et al.
Pageof 15